8/14/2023 0 Comments Insight venture partners anaqua![]() ![]() This announcement follows the recent launch of AQX, Anaqua’s leading-edge software platform. The transaction will accelerate Anaqua’s global organic growth and acquisition strategy. As part of this transaction, Astorg will become the controlling shareholder of Anaqua, replacing Insight Venture Partners and Bessemer Venture Partners, both of which have been investors since 2013. ConvaTec products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.BOSTON-( BUSINESS WIRE)- Anaqua, the leading provider of innovation and intellectual property management solutions, today announced that the business will receive a significant equity investment from Astorg, a leading European private equity firm. Headquartered in the UK, the company has operations in more than 100 countries and almost 10,000 employees worldwide. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia.ĬonvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Anaqua’s AQX platform combines best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations. is a premium provider of integrated intellectual property (IP) management technology solutions and services. We are also delighted to add another global company to our growing portfolio of clients in the healthcare and life sciences sectors.”Īnaqua, Inc. For our part, we look forward to helping ConvaTec protect their innovation and IP management needs. Therefore, it is critically important that we manage our innovation and IP effectively and efficiently – and Anaqua will help ensure we do that.”ĬonvaTec will use Anaqua’s AQX platform for patent and trademark management, annuities and renewals (in conjunction with Anaqua Services), and patent analytics through integration with Anaqua’s AcclaimIP.īob Romeo, CEO of Anaqua, said: “We are proud to be working with and supporting ConvaTec, a company driven by innovation to better serve people around the world in need of advanced medical care. As part of this, one of our key strategic pillars is to innovate in our work and solutions, supported by increased investment in R&D. ![]() ConvaTec products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.Ĭhristina Allegrini, Vice President, Deputy General Counsel & Global Head of Intellectual Property at ConvaTec, said: “Our company vision is to pioneer trusted medical solutions to improve the lives we touch. With operations in more than 100 countries, ConvaTec is a global medical and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence care, critical care, and infusion care. ![]() The agreement further strengthens Anaqua’s position in the medical solutions markets, with a growing number of clients from these sectors collaborating with Anaqua as their preferred IP management provider. Anaqua, the leading innovation and intellectual property management technology provider, announced that global medical products and technologies group ConvaTec will use Anaqua’s AQX platform to help more effectively manage their valuable patent and trademark portfolios. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |